Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies
Melanoma is an aggressive skin cancer with a high rate of metastasis to other organs. Recent studies specified the overexpression of V-domain Ig suppressor of T-cell activation (VISTA) and Aryl Hydrocarbon Receptor (AHR) in melanoma. Metformin shows anti-tumor activities in several cancer types. How...
Saved in:
Main Authors: | Fawaz E. Alanazi (Author), Homood M. As Sobeai (Author), Khalid Alhazzani (Author), Abdullah Al-Dhfyan (Author), Musaad A Alshammari (Author), Moureq Alotaibi (Author), Khaled Al-hosaini (Author), Hesham M. Korashy (Author), Ali Alhoshani (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Whole-exome sequencing identifies cancer-associated variants of the endo-lysosomal ion transport channels in the Saudi population
by: Lama Binobaid, et al.
Published: (2024) -
Antioxidant Functions of the Aryl Hydrocarbon Receptor
by: Cornelia Dietrich
Published: (2016) -
Aryl Hydrocarbon Receptor and Stem Cells
by: Thomas A. Gasiewicz, et al.
Published: (2017) -
Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cells
by: Homood M. As Sobeai, et al.
Published: (2022) -
Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways
by: Abdullah F. AlAsmari, et al.
Published: (2020)